1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => OpenAccess
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)


  
    









































































































































    Subcortical Atrophy Is Associated with Cognitive Impairment in Mild Parkinson Disease: A Combined Investigation of Volumetric Changes, Cortical Thickness, and Vertex-Based Shape Analysis | American Journal of Neuroradiology  
    



















    































    
  
  




    
    

  

      


    

      

  
  
  

    

  

    

  

                
    

      

  

    

  
      
  
  

    


Advertisement



  



  


  
  



  



    

  


  


  


  
  
  
  
  
  

  	      



          


    
      

    
  
    
        
    

  

    
                        

  

                
    

      

	  

		
		

			

			  

  
      
  
  

    

  
  
      
Research ArticleBrain

  
      
Open Access

  
      
Subcortical Atrophy Is Associated with Cognitive Impairment in Mild Parkinson Disease: A Combined Investigation of Volumetric Changes, Cortical Thickness, and Vertex-Based Shape Analysis
  
    	
E. Mak, N. Bergsland, M.G. Dwyer, R. Zivadinov and N. Kandiah

  
    	
American Journal of Neuroradiology December 2014,  35 (12) 2257-2264; DOI: https://doi.org/10.3174/ajnr.A4055 

  
  
  



  


  
  



			

		

	
	
 	
	  
  

		
		

			

			  

  
      
  
  

    
  


  
  



  
      
  
  

    

  

    

  
      
  
  

    
References
  1. 1.↵


    1. 

    2. Muslimovic  D, 
    3. Post  B, 
    4. Speelman  JD, et al
    . Cognitive profile of patients with newly diagnosed Parkinson disease. Neurology 2005;65:1239–45
    CrossRef
  2. 2.↵


    1. 

    2. Sollinger  AB, 
    3. Goldstein  FC, 
    4. Lah  JJ, et al
    . Mild cognitive impairment in Parkinson's disease: subtypes and motor characteristics. Parkinsonism Relat Disord 2010;16:177–80
    CrossRefPubMed
  3. 3.↵


    1. 

    2. Poletti  M, 
    3. Emre  M, 
    4. Bonuccelli  U
    . Mild cognitive impairment and cognitive reserve in Parkinson's disease. Parkinsonism Relat Disord 2011;17:579–86
    CrossRefPubMedWeb of Science
  4. 4.↵


    1. 

    2. Kandiah  N, 
    3. Narasimhalu  K, 
    4. Lau  PN, et al
    . Cognitive decline in early Parkinson's disease. Mov Disord 2009;24:605–08
    CrossRefPubMed
  5. 5.↵


    1. 

    2. Caviness  JN, 
    3. Driver-Dunckley  E, 
    4. Connor  DJ, et al
    . Defining mild cognitive impairment in Parkinson's disease. Mov Disord 2007;22:1272–77
    CrossRefPubMedWeb of Science
  6. 6.↵


    1. 

    2. Litvan  I, 
    3. Aarsland  D, 
    4. Adler  CH, et al
    . MDS task force on mild cognitive impairment in Parkinson's disease: critical review of PD-MCI. Mov Disord 2011;26:1814–24
    CrossRefPubMed
  7. 7.↵


    1. 

    2. Bronnick  K, 
    3. Ehrt  U, 
    4. Emre  M, et al
    . Attentional deficits affect activities of daily living in dementia-associated with Parkinson's disease. J Neurol Neurosurg Psychiatry 2006;77:1136–42
    Abstract/FREE Full Text
  8. 8.↵


    1. 

    2. Aarsland  D, 
    3. Bronnick  K, 
    4. Ehrt  U, et al
    . Neuropsychiatric symptoms in patients with Parkinson's disease and dementia: frequency, profile and associated care giver stress. J Neurol Neurosurg Psychiatry 20062007;78:36–42
  9. 9.↵


    1. 

    2. Levy  G, 
    3. Tang  MX, 
    4. Louis  ED, et al
    . The association of incident dementia with mortality in PD. Neurology 2002;59:1708–13
    CrossRef
  10. 10.↵


    1. 

    2. Owen  AM
    . Cognitive dysfunction in Parkinson's disease: the role of frontostriatal circuitry. Neuroscientist 2004;10:525–37
    Abstract/FREE Full Text
  11. 11.↵


    1. 

    2. Calabresi  P, 
    3. Picconi  B, 
    4. Parnetti  L, et al
    . A convergent model for cognitive dysfunctions in Parkinson's disease: the critical dopamine-acetylcholine synaptic balance. Lancet Neurol 2006;5:974–83
    CrossRefPubMedWeb of Science
  12. 12.↵


    1. 

    2. Pan  PL, 
    3. Shi  HC, 
    4. Zhong  JG, et al
    . Gray matter atrophy in Parkinson's disease with dementia: evidence from meta-analysis of voxel-based morphometry studies. Neurol Sci 2013;34:613–19
    CrossRefPubMed
  13. 13.↵


    1. 

    2. Almeida  OP, 
    3. Burton  EJ, 
    4. McKeith  I, et al
    . MRI study of caudate nucleus volume in Parkinson's disease with and without dementia with Lewy bodies and Alzheimer's disease. Dement Geriatr Cogn Disord 2003;16:57–63
    CrossRefPubMedWeb of Science
  14. 14.↵


    1. 

    2. Burton  EJ, 
    3. McKeith  IG, 
    4. Burn  DJ, et al
    . Cerebral atrophy in Parkinson's disease with and without dementia: a comparison with Alzheimer's disease, dementia with Lewy bodies and controls. Brain 2004;127:791–800
    Abstract/FREE Full Text
  15. 15.↵


    1. 

    2. Junqué  C, 
    3. Ramirez-Ruiz  B, 
    4. Tolosa  E, et al
    . Amygdalar and hippocampal MRI volumetric reductions in Parkinson's disease with dementia. Mov Disord 2005;20:540–44
    CrossRefPubMed
  16. 16.↵


    1. 

    2. Summerfield  C, 
    3. Junque  C, 
    4. Tolosa  E, et al
    . Structural brain changes in Parkinson disease with dementia: a voxel-based morphometry study. Arch Neurol 2005;62:281–85
    CrossRefPubMedWeb of Science
  17. 17.↵


    1. 

    2. Bouchard  TP, 
    3. Malykhin  N, 
    4. Martin  WR, et al
    . Age and dementia-associated atrophy predominates in the hippocampal head and amygdala in Parkinson's disease. Neurobiol Aging 2008;29:1027–39
    CrossRefPubMedWeb of Science
  18. 18.↵


    1. 

    2. Nishio  Y, 
    3. Hirayama  K, 
    4. Takeda  A, et al
    . Corticolimbic gray matter loss in Parkinson's disease without dementia. Eur J Neurol 2010;17:1090–97
    CrossRefPubMed
  19. 19.↵


    1. 

    2. Tessa  C, 
    3. Giannelli  M, 
    4. Della Nave  R, et al
    . A whole-brain analysis in de novo Parkinson disease. AJNR Am J Neuroradiol 2008;29:674–80
    Abstract/FREE Full Text
  20. 20.↵


    1. 

    2. Pereira  JB, 
    3. Ibarretxe-Bilbao  N, 
    4. Marti  MJ, et al
    . Assessment of cortical degeneration in patients with Parkinson's disease by voxel-based morphometry, cortical folding, and cortical thickness. Hum Brain Mapping 2012;33:2521–34
    CrossRefPubMedWeb of Science
  21. 21.↵


    1. 

    2. Tinaz  S, 
    3. Courtney  MG, 
    4. Stern  CE
    . Focal cortical and subcortical atrophy in early Parkinson's disease. Mov Disord 2011;26:436–41
    CrossRefPubMed
  22. 22.↵


    1. 

    2. Ibarretxe-Bilbao  N, 
    3. Junque  C, 
    4. Segura  B, et al
    . Progression of cortical thinning in early Parkinson's disease. Mov Disord 2012;27:1746–53
    CrossRefPubMed
  23. 23.↵


    1. 

    2. Patenaude  B, 
    3. Smith  SM, 
    4. Kennedy  DN, et al
    . A Bayesian model of shape and appearance for subcortical brain segmentation. Neuroimage 2011;56:907–22
    CrossRefPubMedWeb of Science
  24. 24.↵


    1. 

    2. Gelb  DJ, 
    3. Oliver  E, 
    4. Gilman  S
    . Diagnostic criteria for Parkinson disease. Arch Neurol 1999;56:33–39
    CrossRefPubMedWeb of Science
  25. 25.↵


    Movement Disorder Society Task Force on Rating Scales for Parkinson's Disease. The Unified Parkinson's Disease Rating Scale (UPDRS): status and recommendations. Mov Disord 2003;18:738–50
    CrossRefPubMedWeb of Science
  26. 26.↵


    1. 

    2. Hoehn  MM, 
    3. Yahr  MD
    . Parkinsonism: onset, progression, and mortality. Neurology 1967;17:427–42
    CrossRefPubMed
  27. 27.↵


    1. 

    2. Tomlinson  CL, 
    3. Stowe  R, 
    4. Patel  S, et al
    . Systematic review of levodopa dose equivalency reporting in Parkinson's disease. Mov Disord 2010;25:2649–53
    CrossRefPubMedWeb of Science
  28. 28.↵


    1. 

    2. Folstein  MF, 
    3. Robins  LN, 
    4. Helzer  JE
    . The Mini-Mental State Examination. Arch Gen Psychiatry 1983;40:812
    CrossRefPubMedWeb of Science
  29. 29.↵


    1. 

    2. Dalrymple-Alford  JC, 
    3. MacAskill  MR, 
    4. Nakas  CT, et al
    . The MoCA: well-suited screen for cognitive impairment in Parkinson disease. Neurology 2010;75:1717–25
    CrossRef
  30. 30.↵


    1. 

    2. Litvan  I, 
    3. Goldman  JG, 
    4. Tröster  AI, et al
    . Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines. Mov Disord 2012;27:349–56
    CrossRefPubMed
  31. 31.↵


    1. 

    2. Rosen  WG, 
    3. Mohs  RC, 
    4. Davis  KL
    . A new rating scale for Alzheimer's disease. Am J Psychiatry 1984;141:1356–64
    CrossRefPubMedWeb of Science
  32. 32.↵


    1. 

    2. Dubois  B, 
    3. Slachevsky  A, 
    4. Litvan  I, et al
    . The FAB: a frontal assessment battery at bedside. Neurology 2000;55:1621–26
    CrossRefPubMed
  33. 33.↵


    1. 

    2. Sunderland  T, 
    3. Hill  JL, 
    4. Mellow  AM, et al
    . Clock drawing in Alzheimer's disease: a novel measure of dementia severity. J Am Geriatr Soc 1989;37:725–29
    PubMedWeb of Science
  34. 34.↵


    1. 

    2. Jenkinson  M, 
    3. Beckmann  CF, 
    4. Behrens  TE, et al
    . FSL. Neuroimage 2012;62:782–90
    CrossRefPubMedWeb of Science
  35. 35.↵


    1. 

    2. Gelineau-Morel  R, 
    3. Tomassini  V, 
    4. Jenkinson  M, et al
    . The effect of hypointense white matter lesions on automated gray matter segmentation in multiple sclerosis. Hum Brain Mapping 2012;33:2802–14
    CrossRefPubMed
  36. 36.↵


    1. 

    2. Zivadinov  R, 
    3. Heininen-Brown  M, 
    4. Schirda  CV, et al
    . Abnormal subcortical deep-gray matter susceptibility-weighted imaging filtered phase measurements in patients with multiple sclerosis: a case-control study. Neuroimage 2012;59:331–39
    CrossRefPubMedWeb of Science
  37. 37.↵


    1. 

    2. Batista  S, 
    3. Zivadinov  R, 
    4. Hoogs  M, et al
    . Basal ganglia, thalamus and neocortical atrophy predicting slowed cognitive processing in multiple sclerosis. J Neurol 2012;259:139–46
    CrossRefPubMedWeb of Science
  38. 38.↵


    1. 

    2. Hughes  EJ, 
    3. Bond  J, 
    4. Svrckova  P, et al
    . Regional changes in thalamic shape and volume with increasing age. Neuroimage 2012;63:1134–42
    CrossRefPubMedWeb of Science
  39. 39.↵


    1. 

    2. Fischl  B
    . FreeSurfer. Neuroimage 2012;62:774–81
    CrossRefPubMedWeb of Science
  40. 40.↵


    1. 

    2. Genovese  CR, 
    3. Lazar  NA, 
    4. Nichols  T
    . Thresholding of statistical maps in functional neuroimaging using the false discovery rate. Neuroimage 2002;15:870–78
    CrossRefPubMedWeb of Science
  41. 41.↵


    1. 

    2. Lyoo  CH, 
    3. Ryu  YH, 
    4. Lee  MS
    . Topographical distribution of cerebral cortical thinning in patients with mild Parkinson's disease without dementia. Mov Disord 2010;25:496–99
    CrossRefPubMed
  42. 42.↵


    1. 

    2. Melzer  TR, 
    3. Watts  R, 
    4. MacAskill  MR, et al
    . Grey matter atrophy in cognitively impaired Parkinson's disease. J Neurol Neurosurg Psychiatry 2012;83:188–94
    Abstract/FREE Full Text
  43. 43.↵


    1. 

    2. Song  SK, 
    3. Lee  JE, 
    4. Park  HJ, et al
    . The pattern of cortical atrophy in patients with Parkinson's disease according to cognitive status. Mov Disord 2011;26:289–96
    CrossRefPubMed
  44. 44.↵


    1. 

    2. Dalaker  TO, 
    3. Zivadinov  R, 
    4. Larsen  JP, et al
    . Gray matter correlations of cognition in incident Parkinson's disease. Mov Disord 2010;25:629–33
    CrossRefPubMed
  45. 45.↵


    1. 

    2. Herrero  MT, 
    3. Barcia  C, 
    4. Navarro  JM
    . Functional anatomy of thalamus and basal ganglia. Childs Nerv Syst 2002;18:386–404
    CrossRefPubMedWeb of Science
  46. 46.↵


    1. 

    2. de la Monte  SM, 
    3. Wells  SE, 
    4. Hedley-Whyte  T, et al
    . Neuropathological distinction between Parkinson's dementia and Parkinson's plus Alzheimer's disease. Ann Neurol 1989;26:309–20
    CrossRefPubMedWeb of Science
  47. 47.↵


    1. 

    2. de Jong  LW, 
    3. van der Hiele  K, 
    4. Veer  IM, et al
    . Strongly reduced volumes of putamen and thalamus in Alzheimer's disease: an MRI study. Brain 2008;131:3277–85
    Abstract/FREE Full Text
  48. 48.↵


    1. 

    2. Kassubek  J, 
    3. Juengling  FD, 
    4. Ecker  D, et al
    . Thalamic atrophy in Huntington's disease co-varies with cognitive performance: a morphometric MRI analysis. Cereb Cortex 2005;15:846–53
    Abstract/FREE Full Text
  49. 49.↵


    1. 

    2. Benedict  RH, 
    3. Hulst  HE, 
    4. Bergsland  N, et al
    . Clinical significance of atrophy and white matter mean diffusivity within the thalamus of multiple sclerosis patients. Mult Scler 2013;19:1478–84
    Abstract/FREE Full Text
  50. 50.↵


    1. 

    2. Goldenberg  G, 
    3. Schuri  U, 
    4. Gromminger  O, et al
    . Basal forebrain amnesia: does the nucleus accumbens contribute to human memory? J Neurol Neurosurg Psychiatry 1999;67:163–68
    Abstract/FREE Full Text
  51. 51.↵


    1. 

    2. de Jong  LW, 
    3. Wang  Y, 
    4. White  LR, et al
    . Ventral striatal volume is associated with cognitive decline in older people: a population based MR-study. Neurobiol Aging 2012;33:424.e1–10
    CrossRefPubMed
  52. 52.↵


    1. 

    2. van Beilen  M, 
    3. Leenders  KL
    . Putamen FDOPA uptake and its relationship to cognitive functioning in PD. J Neurol Sci 2006;248:68–71
    CrossRefPubMed
  53. 53.↵


    1. 

    2. Zarei  M, 
    3. Ibarretxe-Bilbao  N, 
    4. Compta  Y, et al
    . Cortical thinning is associated with disease stages and dementia in Parkinson's disease. J Neurol Neurosurg Psychiatry 2013;84:875–81
    Abstract/FREE Full Text
  54. 54.↵


    1. 

    2. Lee  HM, 
    3. Kwo  KY, 
    4. Kim  MJ, et al
    . Subcortical grey matter changes in untreated, early stage Parkinson's disease without dementia. Parkinsonism Relat Disord 2014;20:622–26
    CrossRefPubMed
  55. 55.↵


    1. 

    2. Rinne  JO, 
    3. Mlic  JR, 
    4. Paljärvi  L, et al
    . Dementia in Parkinson's disease is related to neuronal loss in the medial substantia nigra. Ann Neurol 1989;26:47–50
    CrossRefPubMedWeb of Science
  


  
  



  




  


  
  



  
      
  
  

    
  


  
  



  
      
  
  

     Back to top  


  
  



			

		

		
		

			

			  

  
        
In this issue

    
  
  

    
  


  
  



  
      
  
  

    

  

    

  
      
  
  

    


Advertisement



  



  


  
  



  



  


  
  



  
      
  
  

    

	  
  

		

          

            

  
      
  
  

     Print  


  
  



  
      
  
  

     Download PDF  


  
  



  
      
  
  

    
 Email Article
  


  
  



  
      
  
  

    
 Citation Tools
  


  
  



          

        

        
        

          

            



  
      
  
  

    

  

    

  
      
  
  

    

  
  
  
  
      
Subcortical Atrophy Is Associated with Cognitive Impairment in Mild Parkinson Disease: A Combined Investigation of Volumetric Changes, Cortical Thickness, and Vertex-Based Shape Analysis
  
    	
E. Mak, N. Bergsland, M.G. Dwyer, R. Zivadinov, N. Kandiah

  
    	
 American Journal of Neuroradiology Dec 2014, 35 (12) 2257-2264; DOI: 10.3174/ajnr.A4055 

  
  
  



  


  
  



  
      
  
  

    

  
    
  
  
    
  
  
    
  


  


  
  



  
      
  
  

    
del.icio.us logo Twitter logo Facebook logo Mendeley logo
  


  
  



  



  


  
  



  
      
  
  

    
  


  
  



          

        

	
 	
	
	


  


  
  



  
      
  
  

    
              Purchase  


  
  



  
        
Jump to section

    
  
  

    
  


  
  



  
      
  
  

    
  


  
  



			

		

	
	
 	
	
	


    

  



  

                
    

      

  

    

  
      
  
  

    


Advertisement